Mode
Text Size
Log in / Sign up
N/A Completed N=61 Randomized Single-blind Treatment

Relationship to Dose of Triamcinolone Acetonide and Methylyprednisolone to Improvement in Subacromial Bursitis

Subacromial Bursitis · Postoperative Pain
Source: ClinicalTrials.gov NCT02242630 ↗
Enrolled (actual)
61
Serious AEs
0.0%
Results posted
Dec 2016
Primary outcomePrimary: Change in Shoulder Function, as Measured by the QuickDASH ® — 19.2; 21.3; 19.1; 24.7 units on a scale

Summary

It is currently unknown whether or not the improvement in pain and function related to a "steroid shot" for shoulder pain due to subacromial bursitis is important. This study seeks to determine whether 20 mg or 40 mg of either triamcinolone or methylprednisolone significantly affect improvement in shoulder pain 6 weeks after injection.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Shoulder Function, as Measured by the QuickDASH ®
19.2; 21.3; 19.1; 24.7
SECONDARY
Change in Subject Reported Shoulder Pain as Measured by the Visual Analogue Scale
1.0; 1.8; 1.9; 1.8

Eligibility Criteria

Inclusion Criteria

  • Age 18 years or older
  • History and physical examination consistent with shoulder pain and subacromial bursitis
  • At least 2 weeks of shoulder pain and subacromial bursitis

Exclusion Criteria

  • Known allergies to Lidocaine, Marcaine, Methylprednisolone, and/or Triamcinolone
  • History or examination suspicious for a humeral head fracture
  • History or examination consistent with adhesive capsulitis (normal X-Ray of the shoulder but with less than 100 degrees of active or passive elevation of the arm, when raising the arm above the head to a maximum with passive external rotation being 50 degrees less than the unaffected side
  • History or examination consistent with acute synovitis of the glenohumeral or acromioclavicular joint
  • Any shoulder surgery involving the affected arm within the last 6 months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02242630). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search